Recombinant porcine factor VIII in acquired hemophilia A: Experience from two patients and literature review
Abstract Background Acquired hemophilia A (AHA) is a disease caused by antibody formation inhibiting the function of factor VIII, causing bleeding. Recombinant porcine factor VIII (rpFVIII) escapes human FVIII antibody recognition and can provide life‐saving hemostasis. However, the development of a...
| Published in: | Research and Practice in Thrombosis and Haemostasis |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-02-01
|
| Online Access: | https://doi.org/10.1002/rth2.12688 |